Stanford-StartX Fund, an investment vehicle backed by the university, has had its lawsuit against US-based virtual medical assistant developer MedWhat sent to a mediation panel, Analytics Insight has reported. Mediation will involve both parties seeking an amicable solution, or “alternative dispute resolution”, to the case, which was initially filed with the Superior Court of California in the County of San Francisco on April 9. Stanford-StartX has not publicly stated why it is pursuing MedWhat, though a legal document indicates it is acting in consort with Caixa Capital, Regent Capital Ventures and Startcaps Ventures. Lawyers representing the plaintiffs objected to mediation but have had their concerns overruled. MedWhat is developing a medical chatbot that relies on artificial intelligence to assess a user’s symptoms before suggesting the best remedies for any health conditions they may have. The company’s long-term aim is to develop a platform that matches human-level intelligence in medicine. The company graduated from the 2013 cohort of StartX and also participated in software company Microsoft’s accelerator in 2016. Stanford-StartX Fund first backed MedWhat as part of a $560,000 seed round in 2014 together with Stanford Hospital, Startcaps Ventures and assorted angel investors. The fund later provided undisclosed amounts of follow-on funding in 2015 and 2017. Regulatory filings indicate MedWhat obtained at least $2.6m in capital last year.
MedWhat case mandated for mediation
May 18, 2018 •
LEADERSHIP SOCIETY
Informing, connecting, and transforming the global corporate venture capital ecosystem.The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.
More featured content
Halo has researchers on speed dial for corporates
Halo has researchers on speed dial for corporates
How does a corporate find the right university researcher or startup when it's trying to solve a critical problem? Halo has the answer.
How Basel supercharged its spinout rate
How Basel supercharged its spinout rate
Basel has quietly built a life sciences ecosystem that’s becoming hard to ignore.
Crumbling system, fragile lives: can spinouts help in the senior care crisis?
Crumbling system, fragile lives: can spinouts help in the senior care crisis?
From a chest-worn device to help with Parkinson's symptoms to stress measuring socks — here are the spinouts providing support for senior citizens.
Events
Webinar: Innovate to heal - What does the hospital of the future look like?
Apr 10, 2024
Online
Online
Events
GCV Institute: Landing the Value of Corporate Venturing
May 6 -
May 9, 2024
Online
May 9, 2024
Online
Events
GCV Institute: CVC Investment Programs
May 21 -
May 22, 2024
Online
May 22, 2024
Online
Events
GCV Symposium 2024
Jun 24 -
Jun 26, 2024
London (UK)
Jun 26, 2024
London (UK)
Events
Corporate Venture in Brasil 2024 – International Delegation to Brazil
Oct 28 -
Oct 30, 2024
São Paulo (Brazil)
Oct 30, 2024
São Paulo (Brazil)
Top News
test reg